This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignee: Drexel University. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2025
Title: Felix Kim: Innovator in Pharmaceutical Compounds
Introduction
Felix Kim is a prominent inventor based in Philadelphia, PA (US), known for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he has made strides in developing compounds and methods aimed at treating various diseases, particularly cancer.
Latest Patents
Felix Kim's latest patents focus on compounds, compositions, and methods for treating diseases. One of his notable applications is directed towards compounds and/or pharmaceutically acceptable salts or solvates, which modulate the activity of the Sigma1 receptor. This application also outlines methods for treating and/or preventing cancer using the disclosed compounds and compositions. His innovative work in this area highlights the potential for new therapeutic approaches in oncology.
Career Highlights
Felix Kim is affiliated with Drexel University, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical treatments and patient care. The combination of his academic background and practical applications of his inventions positions him as a key figure in pharmaceutical innovation.
Collaborations
Felix collaborates with Joseph M Salvino, enhancing the scope and depth of his research endeavors. Their partnership exemplifies the collaborative spirit often found in academic and research institutions, driving forward the boundaries of knowledge and innovation.
Conclusion
Felix Kim's contributions to the field of pharmaceuticals through his patents and research at Drexel University underscore his role as an influential inventor. His work not only addresses critical health challenges but also paves the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
